DMD

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Awasthi, S.
Right arrow Articles by Awasthi, Y. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Awasthi, S.
Right arrow Articles by Awasthi, Y. C.

Vol. 30, Issue 12, 1300-1310, December 2002

MINIREVIEW
RLIP76, a Novel Transporter Catalyzing ATP-Dependent Efflux of Xenobiotics

Sanjay Awasthi, Rajendra Sharma, Sharad S. Singhal, Piotr Zimniak, and Yogesh C. Awasthi

Department of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, Texas (S.A., S.S.S.); Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, Texas (R.S., Y.C.A.); and Department of Internal Medicine and Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, and Central Arkansas Veterans Healthcare System, Little Rock, Arkansas (P.Z.)

Transport of xenobiotics and their metabolites by ATP-binding cassette (ABC) transporters particularly P-glycoprotein (Pgp) and the multidrug resistance associated protein (MRP1) has been extensively studied during last decade. Our recent studies demonstrate that RLIP76, a previously known GTPase-activating protein catalyzes ATP-dependent, uphill transport of anionic glutathione conjugates as well as of weakly cationic anthracyclines including doxorubicin (Adriamycin), a widely used drug in cancer chemotherapy. RLIP76 has inherent ATPase activity, which is stimulated by doxorubicin and glutathione conjugates. RLIP76 does not meet the criteria for classical ABC proteins such as MRP1 or Pgp, but similar to ABC proteins, it has two ATP-binding sequences, 69GKKKGK74 and 418GGIKDLSK425. Mutations in these sequences abrogate its ATP-binding, ATPase activity, and transport function. Purified RLIP76 when reconstituted in proteoliposomes mediates ATP-dependent saturable transport of doxorubicin and glutathione conjugates. Transfection of K562 cells with RLIP76 confers these cells resistance to doxorubicin and 4-hydroxynonenal. Cells enriched with RLIP76 also acquire resistance to radiation toxicity. RLIP76 also catalyzes the transport of physiologic ligands such as leukotrienes (LTC4) and the conjugate of 4-hydroxynonenal and glutathione. In some cells (e.g., erythrocytes and lung cancer cells), the majority of transport activity for Adriamycin and glutathione conjugates including LTC4 is accounted for by RLIP76. These studies strongly suggest that RLIP76-mediated transport of organic ions has physiological and toxicological relevance and that it may play an important role in the mechanism of drug resistance.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Yang, A. Sharma, R. Sharma, B. Patrick, S. S. Singhal, P. Zimniak, S. Awasthi, and Y. C. Awasthi
Cells Preconditioned with Mild, Transient UVA Irradiation Acquire Resistance to Oxidative Stress and UVA-induced Apoptosis: ROLE OF 4-HYDROXYNONENAL IN UVA-MEDIATED SIGNALING FOR APOPTOSIS
J. Biol. Chem., October 17, 2003; 278(42): 41380 - 41388.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. Sharma, Y. Yang, A. Sharma, S. Dwivedi, V. L. Popov, P. J. Boor, S. S. Singhal, S. Awasthi, and Y. C. Awasthi
Mechanisms and Physiological Significance of the Transport of the Glutathione Conjugate of 4-Hydroxynonenal in Human Lens Epithelial Cells
Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3438 - 3449.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.